155289-55-7Relevant academic research and scientific papers
Cyclic Benzamides as Mixed Dopamine D2/Serotonin 5-HT2 Receptor Antagonists: Potential Atypical Antipsychotic Agents
Norman, Mark H.,Rigdon, Greg C.,Navas, Frank,Cooper, Barrett R.
, p. 2552 - 2563 (1994)
A series of novel 4-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)butyl cyclic amides was prepared and evaluated as potential antipsychotic agents. The target compounds were examined in vitro for their binding affinities to the dopamine D2, serotonin 5-HT2,
